skip to main content
Show Results with:

Deriving health utility values from a randomized, double-blind, placebo-controlled trial of siltuximab in subjects with multicentric Castleman's disease

Vernon, Margaret et al.

Current medical research and opinion. Volume 32:Number 7 (2016, July); pp 1193-1200 -- Informa Healthcare

Online access

Searching Remote Databases, Please Wait